US Patent 11771733 Lisinopril formulations
Patent 11771733 was granted and assigned to Silvergate Pharmaceuticals, Inc. on October, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Oct, 2023
Golden AI
Edits made to:
Infobox (+34 properties)
Article (+265 characters)
US Patent 11771733 Lisinopril formulations
Article
Patent abstract
Provided herein are stable lisinopril oral liquid formulations. Also provided herein are methods of using lisinopril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and acute myocardial infarction.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
David W. Miles
Gerold L. Mosher
Date of Patent
October 3, 2023
Patent Application Number
17507144
Date Filed
October 21, 2021
Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11771733 Lisinopril formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.